CTI BioPharma Corp.
Utility Patent Applications

Last updated:

List of all CTI BioPharma Corp. patents 4 in total

Status Patent
Application
Utility: OXYGEN LINKED PYRIMIDINE DERIVATIVES External link
Filling date: 26 Sep 2025 Issue date: 4 Aug 2022
Application
Utility: METHODS OF TREATING FLT3-MUTATED HEMATOLOGIC CANCERS External link
Filling date: 26 Sep 2025 Issue date: 13 Jan 2022
Application
Utility: METHODS OF TREATING TRANSPLANT REJECTION External link
Filling date: 26 Sep 2025 Issue date: 11 Mar 2021
Application
Utility: OXYGEN LINKED PYRIMIDINE DERIVATIVES External link
Filling date: 26 Sep 2025 Issue date: 5 Mar 2020

Showing 1 to 4 of 4 patents.